Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Archaeal surface layer (S-layer) is a paracrystalline monomolecular assembly of protein or glycoprotein subunits that constitutes the outermost component of the cell envelope in nearly all Archaea (Sleytr et al., 2014). It serves as a primary structural element, providing mechanical stability, maintaining cell shape, and acting as a selective molecular sieve for nutrient and waste exchange (Albers & Meyer, 2011). Unlike bacterial cell walls that often contain peptidoglycan, many Archaea rely solely on the S-layer for protection against extreme environmental conditions such as high temperature, extreme pH, or high salinity (Rodrigues-Oliveira et al., 2017). The S-layer also facilitates cell-cell interactions and provides a scaffold for the attachment of other surface structures like flagella or pili (Albers & Meyer, 2011). While Archaea are prominent members of the human microbiome, particularly in the gut and oral cavity, they are not currently recognized as primary human pathogens (Gill & Enfield, 2017). Because of this lack of pathogenicity, Archaeal S-layer proteins are not currently utilized as targets for conventional antimicrobial or therapeutic drugs. However, their unique ability to self-assemble into highly ordered lattices makes them valuable in nanobiotechnology for developing drug delivery systems and biosensors (Sleytr et al., 2014). They are also being explored as adjuvant platforms in vaccine development due to their inherent immunogenicity and stability (Sleytr et al., 2014).
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Archaeal surface layer protein (SLP).